As of June 21, 2025, Radient Technologies Inc (RTI.V) reports a Net Margin of -357.01%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Radient Technologies Inc's Net Margin
Over recent years, Radient Technologies Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2022-03-31 | -357.01% |
| 2021-03-31 | -1697.85% |
| 2020-03-31 | -203.31% |
| 2019-03-31 | -13012.97% |
| 2018-03-31 | -3081.92% |
This slight downward trend highlights how Radient Technologies Inc manages its overall profitability and cost control over time.
Comparing Radient Technologies Inc's Net Margin to Peers
To better understand Radient Technologies Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Radient Technologies Inc (RTI.V) | -357.01% |
| Biosyent Inc (RX.V) | 20.75% |
| Polydex Pharmaceuticals Ltd (POLXF) | 4.36% |
| Hubei Minkang Pharmaceutical Ltd (HBMK) | 0.86% |
| Sunwin Stevia International Inc (SUWN) | -8.25% |
| Delta 9 Cannabis Inc (DN.TO) | -24.65% |
Compared to its competitors, Radient Technologies Inc's Net Margin is among the lowest compared to peers, which may indicate challenges in controlling expenses or competitive pricing pressures.